Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction

European Journal of Echocardiography

Volumn 12, Issue 6, 2011, Pages 454-460

  Joshi, Kruti ^a   Alam, Irshad ^a   Ruden, Emily ^a   Gradus Pizlo, Irmina ^a   Mahenthiran, Jothiharan ^a   Kamalesh, Masoor ^a   Feigenbaum, Harvey ^a   Sawada, Stephen ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Ejection fraction improvement; Ischaemic cardiomyopathy; Prognosis; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DOBUTAMINE;

ADULT; ANGINA PECTORIS; ARTICLE; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE WALL MOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SURVIVAL; SYSTOLIC DYSFUNCTION;

ECHOCARDIOGRAPHY, STRESS; HEALTH STATUS INDICATORS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STATISTICS AS TOPIC; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 80051974511     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jer045     Document Type: Article

References (26)

1. Wong M, Staszewsky L, Latini R, Barlera S, Glazer R, Aknay N et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol 2004;43:2022-7. (Pubitemid 38686796)
2. Acampa W, Petretta M, Spinelli L, Salvatore M, Cuoculo A. Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium. Eur J Nucl Med Mol Imaging 2005;32:430-7. (Pubitemid 40591175)
3. Samady H, Eldfteriades JH, Abott BG, Mattera JA, McPherson CA, Wackers FJ. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-304. (Pubitemid 29440122)
4. Rizzello V, Poldermans D, Biagini E, Schinkel AF, Boersma E, Boccanelli A et al. Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart 2009;95:1273-7.
5. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998;32:912-20. (Pubitemid 28459578)
6. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
7. Sawada S, Bapat A, Vaz D, Weksler J, Fineberg N, Greene A et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 2003;42:2099-105. (Pubitemid 37549892)
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. (Pubitemid 41821197)
9. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
10. Rizzello V, Poldermans D, Schinkel A, Biagini E, Boersma E, Elhendy A. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2006;92:239-44. (Pubitemid 43131969)
11. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6. (Pubitemid 16183061)
12. Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9. (Pubitemid 26289218)
13. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Reijs AE et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28:558-64.
14. vom Dahl J, Eitzman DT, al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66. (Pubitemid 24354322)
15. D'Egidio G, Nichol G, Williams KA, Guo A, Garrard K, de Kemp R et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging 2009;2:1060-8.
16. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE, Schalij MJ. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 2003;108:1954-9. (Pubitemid 37303911)
17. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.
18. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
19. Brugada J, Aguinaga L, Mont L, Betriu A, Mulet J, Sanz G. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol 2001;37:529-33.
20. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8. (Pubitemid 37430346)
21. Adams KF Jr, Patterson JH, Gattis WA, O'connor CM, Lee CR, Schwartz TA et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 2005;46:497-504. (Pubitemid 41040292)
22. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-33. (Pubitemid 43739439)
23. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7. (Pubitemid 27255495)
24. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113:203-12.
25. McGlynn EA, Adams J, Keesey J, Keesey J, Hicks J, De Cristofaro A et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45. (Pubitemid 36741592)
26. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21.